← All trials
NCT05761405
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 16, 2023
- Primary completion
- Oct 15, 2025
- Completion date
- Apr 15, 2026
- First posted
- Mar 9, 2023
- Last posted
- Aug 30, 2023
- Enrollment
- 90
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of LausanneLead sponsor
- University of LausanneOverall official - principal investigator
- University of LausanneReponsible party - principal investigator
- University of BernCollaborator
- Ecole Polytechnique Fédérale de LausanneCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.